Search - tctmd.com

Displaying 61 - 80 of 891

Sort: Relevancy | Date

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

Lucy Hicks

September 26, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Presenter: John G. Webb

September 23, 2018

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

Advertisement

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Portico Noninferior to Commercial TAVR Valves in IDE Study

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

TCT 2019 Day Two: Transcatheter Valves, New and Old

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

High Mortality but Durable Results With Valve-in-Valve TAVR

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content